These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8291228

  • 21. Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.
    Monroe JG, Kass MJ.
    J Immunol; 1985 Sep; 135(3):1674-82. PubMed ID: 2410499
    [Abstract] [Full Text] [Related]

  • 22. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT.
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [Abstract] [Full Text] [Related]

  • 23. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [Abstract] [Full Text] [Related]

  • 24. Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.
    Wang YC, Huang JM, Montalvo EA.
    Virology; 1997 Jan 20; 227(2):323-30. PubMed ID: 9018131
    [Abstract] [Full Text] [Related]

  • 25. Strain variation in Epstein-Barr virus immediate early genes.
    Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ.
    Virology; 1993 Feb 20; 192(2):541-50. PubMed ID: 8093650
    [Abstract] [Full Text] [Related]

  • 26. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
    Iwakiri D, Takada K.
    J Immunol; 2004 Feb 01; 172(3):1561-6. PubMed ID: 14734735
    [Abstract] [Full Text] [Related]

  • 27. Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.
    Wu H, Li T, Zeng M, Peng T.
    Cell Microbiol; 2012 Apr 01; 14(4):546-59. PubMed ID: 22188237
    [Abstract] [Full Text] [Related]

  • 28. Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells.
    Dennis G, June CH, Mizuguchi J, Ohara J, Witherspoon K, Finkelman FD, McMillan V, Mond JJ.
    J Immunol; 1987 Oct 15; 139(8):2516-23. PubMed ID: 2821117
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K.
    J Virol; 2007 Jan 15; 81(2):1037-42. PubMed ID: 17079287
    [Abstract] [Full Text] [Related]

  • 30. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation.
    Hong Y, Holley-Guthrie E, Kenney S.
    Virology; 1997 Mar 03; 229(1):36-48. PubMed ID: 9123876
    [Abstract] [Full Text] [Related]

  • 31. [The mechanisms of Epstein-Barr virus activation in B cells].
    Sairenji T.
    Nihon Rinsho; 1997 Feb 03; 55(2):316-20. PubMed ID: 9046817
    [Abstract] [Full Text] [Related]

  • 32. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.
    Liu P, Liu S, Speck SH.
    J Virol; 1998 Oct 03; 72(10):8230-9. PubMed ID: 9733866
    [Abstract] [Full Text] [Related]

  • 33. Evidence for protein tyrosine kinase involvement in CD6-induced T cell proliferation.
    Osorio LM, Ordonez C, Garcia CA, Jondal M, Chow SC.
    Cell Immunol; 1995 Nov 03; 166(1):44-52. PubMed ID: 7585980
    [Abstract] [Full Text] [Related]

  • 34. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE.
    J Virol; 2001 Jan 03; 75(2):867-77. PubMed ID: 11134300
    [Abstract] [Full Text] [Related]

  • 35. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
    Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rösl F.
    Mol Carcinog; 2002 Mar 03; 33(3):137-45. PubMed ID: 11870879
    [Abstract] [Full Text] [Related]

  • 36. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
    Nutter LM, Grill SP, Li JS, Tan RS, Cheng YC.
    Cancer Res; 1987 Aug 15; 47(16):4407-12. PubMed ID: 3038311
    [Abstract] [Full Text] [Related]

  • 37. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
    Shimizu N, Takada K.
    J Virol; 1993 Jun 15; 67(6):3240-5. PubMed ID: 8388498
    [Abstract] [Full Text] [Related]

  • 38. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.
    Schwarzmann F, Prang N, Reichelt B, Rinkes B, Haist S, Marschall M, Wolf H.
    J Gen Virol; 1994 Aug 15; 75 ( Pt 8)():1999-2006. PubMed ID: 8046403
    [Abstract] [Full Text] [Related]

  • 39. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
    Gutiérrez MI, Ibrahim MM, Dale JK, Greiner TC, Straus SE, Bhatia K.
    J Natl Cancer Inst; 2002 Dec 04; 94(23):1757-63. PubMed ID: 12464647
    [Abstract] [Full Text] [Related]

  • 40. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
    Sun CC, Thorley-Lawson DA.
    J Virol; 2007 Dec 04; 81(24):13566-77. PubMed ID: 17898050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.